138 related articles for article (PubMed ID: 27039993)
21. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
[TBL] [Abstract][Full Text] [Related]
22. Newborn screening for Pompe disease: an update, 2011.
Burton BK
Am J Med Genet C Semin Med Genet; 2012 Feb; 160C(1):8-12. PubMed ID: 22253219
[TBL] [Abstract][Full Text] [Related]
23. Adult glycogenosis type II (Pompe's disease): morphological abnormalities in muscle and skin biopsies compared with acid alpha-glucosidase activity.
Wierzba-Bobrowicz T; Lewandowska E; Lugowska A; Rola R; Stepień T; Ryglewicz D; Pasennik E
Folia Neuropathol; 2007; 45(4):179-86. PubMed ID: 18176891
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of Pompe disease: muscle biopsy vs blood-based assays.
Vissing J; Lukacs Z; Straub V
JAMA Neurol; 2013 Jul; 70(7):923-7. PubMed ID: 23649721
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness.
Lukacs Z; Nieves Cobos P; Wenninger S; Willis TA; Guglieri M; Roberts M; Quinlivan R; Hilton-Jones D; Evangelista T; Zierz S; Schlotter-Weigel B; Walter MC; Reilich P; Klopstock T; Deschauer M; Straub V; Müller-Felber W; Schoser B
Neurology; 2016 Jul; 87(3):295-8. PubMed ID: 27170567
[TBL] [Abstract][Full Text] [Related]
26. Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease specific pathology.
Tsuburaya RS; Monma K; Oya Y; Nakayama T; Fukuda T; Sugie H; Hayashi YK; Nonaka I; Nishino I
Neuromuscul Disord; 2012 May; 22(5):389-93. PubMed ID: 22196155
[TBL] [Abstract][Full Text] [Related]
27. Late-onset pompe disease in Iran: A clinical and genetic report.
Nazari F; Sinaei F; Nilipour Y; Fatehi F; Streubel B; Ashrafi MR; Aryani O; Nafissi S
Muscle Nerve; 2017 Jun; 55(6):835-840. PubMed ID: 27649523
[TBL] [Abstract][Full Text] [Related]
28. Rigid spine syndrome revealing late-onset Pompe disease.
Laforêt P; Doppler V; Caillaud C; Laloui K; Claeys KG; Richard P; Ferreiro A; Eymard B
Neuromuscul Disord; 2010 Feb; 20(2):128-30. PubMed ID: 20005713
[TBL] [Abstract][Full Text] [Related]
29. Presymptomatic late-onset Pompe disease identified by the dried blood spot test.
Wagner M; Chaouch A; Müller JS; Polvikoski T; Willis TA; Sarkozy A; Eagle M; Bushby K; Straub V; Lochmüller H
Neuromuscul Disord; 2013 Jan; 23(1):89-92. PubMed ID: 23062590
[TBL] [Abstract][Full Text] [Related]
30. Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and/or hyperCKemia.
Pérez-López J; Selva-O'Callaghan A; Grau-Junyent JM; Gallego-Galindo L; Coll MJ; García-Morillo S; Torralba-Cabeza MA; Vilardell-Tarrés M
Mol Genet Metab; 2015 Apr; 114(4):580-3. PubMed ID: 25752415
[TBL] [Abstract][Full Text] [Related]
31. Periodic acid-Schiff staining on resin muscle sections: improvement in the histological diagnosis of late-onset Pompe disease.
Terracciano C; Rastelli E; Massa R
Muscle Nerve; 2012 Apr; 45(4):611-2. PubMed ID: 22431097
[No Abstract] [Full Text] [Related]
32. Development of a feasible assay for the detection of GAA mutations in patients with Pompe disease.
Er TK; Chen CC; Chien YH; Liang WC; Kan TM; Jong YJ
Clin Chim Acta; 2014 Feb; 429():18-25. PubMed ID: 24444888
[TBL] [Abstract][Full Text] [Related]
33. Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots.
Shigeto S; Katafuchi T; Okada Y; Nakamura K; Endo F; Okuyama T; Takeuchi H; Kroos MA; Verheijen FW; Reuser AJ; Okumiya T
Mol Genet Metab; 2011 May; 103(1):12-7. PubMed ID: 21320792
[TBL] [Abstract][Full Text] [Related]
34. Blood-based diagnostic testing for Pompe disease: consistency between GAA enzyme activity in dried blood spots and GAA gene sequencing results.
Goldstein JL; Dickerson G; Kishnani PS; Rehder C; Bali DS
Muscle Nerve; 2014 May; 49(5):775-6. PubMed ID: 24338800
[No Abstract] [Full Text] [Related]
35. Pompe disease: early diagnosis and early treatment make a difference.
Chien YH; Hwu WL; Lee NC
Pediatr Neonatol; 2013 Aug; 54(4):219-27. PubMed ID: 23632029
[TBL] [Abstract][Full Text] [Related]
36. Update of the Pompe disease mutation database with 107 sequence variants and a format for severity rating.
Kroos M; Pomponio RJ; van Vliet L; Palmer RE; Phipps M; Van der Helm R; Halley D; Reuser A;
Hum Mutat; 2008 Jun; 29(6):E13-26. PubMed ID: 18425781
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis recommendations for late-onset Pompe disease].
Brito-Avô L; Alves JD; Costa JM; Valverde A; Santos L; Araújo F; Aguiar P; Marinho A; Oliveira A; Gomes D
Acta Med Port; 2014; 27(4):525-9. PubMed ID: 25203965
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possibility for newborn screening.
Lukacs Z; Nieves Cobos P; Mengel E; Hartung R; Beck M; Deschauer M; Keil A; Santer R
J Inherit Metab Dis; 2010 Feb; 33(1):43-50. PubMed ID: 20033296
[TBL] [Abstract][Full Text] [Related]
39. Screening for Pompe disease in a Portuguese high risk population.
Almeida V; Conceição I; Fineza I; Coelho T; Silveira F; Santos M; Valverde A; Geraldo A; Maré R; Aguiar TC; Mendonça C; Martins J; Medeiros L; Barroso C; Vieira JP; Moreno T; Negrão L; Dias MS; Lacerda L; Evangelista T
Neuromuscul Disord; 2017 Aug; 27(8):777-781. PubMed ID: 28554557
[TBL] [Abstract][Full Text] [Related]
40. Muscle MRI findings in siblings with juvenile-onset acid maltase deficiency (Pompe disease).
Dlamini N; Jan W; Norwood F; Sheehan J; Spahr R; Al-Sarraj S; Anthony Hulse J; Hughes D; Champion MP; Jungbluth H
Neuromuscul Disord; 2008 May; 18(5):408-9. PubMed ID: 18434155
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
